Is this a good Strategy Proposal? In my review of the Brookings Institute report, I see many reasons for the high cost of health care in the United States. A lack of transparency in pricing and wild variations in pricing even within the same regional market is very evident. The report cites that the same blood test in El Paso, Texas can range from $144 - $952. "Much of the variation is likely related to market imperfections that limit the ability and incentive for patients to shop for the lowest price." (Nunn, Parsons, & Shambaugh, pp.13, 2020) I believe that there should be not only transparency in pricing, but there should be reasonable regulatory controls and capitation of pricing. While there may need to be some state to state variations associated with some reasonable varying cost, the end consumer should be able to expect to know what they are paying, before they have to pay for it. This capitation in pricing to the end consumer, would also involve capitation expenses to the health care institution as well. Pharmaceutical companies should only be able to charge a certain dollar amount to institutions and consumers for drugs, supply companies should only be